title: The concept of cardioreparation: Part 1. Pathophysiology of remodelling.
abstract: OBJECTIVE
  Left ventricular hypertrophy is common in patients with hypertension or congestive heart failure and in survivors of myocardial infarction. It is associated with increased risks of adverse cardiovascular events, including angina, myocardial infarction and congestive heart failure. We aimed to explain these observations in terms of changes in the structure of the heart, collectively described as remodelling.
  
  
  METHODS
  Laboratory investigations of animal models of cardiovascular diseases were reviewed. The most prominent features of remodelling are myocyte hypertrophy, excessive accumulation of collagen in the heart (myocardial fibrosis) and pathological changes in the coronary blood vessels. Remodelling disrupts the structure of the heart and impairs its pumping function and blood supply. The reversal of remodelling, termed cardioreparation, could restore cardiac structure and function towards normal and improve the prognosis of patients with cardiovascular diseases.
  
  
  CONCLUSIONS
  Cardioreparation implies the regression of myocyte hypertrophy and myocardial fibrosis. Myocyte hypertrophy is primarily a response to chronic pressure or volume overload of the ventricles, whereas myocardial fibrosis depends on activation of circulating and tissue renin-angiotensin-aldosterone systems. Angiotensin converting enzyme inhibitors reduce blood pressure and inhibit these systems. They might therefore induce cardioreparation.
authors.affiliation: Division of Cardiology, Philipps University of Marburg, Germany.
authors.forename: C G
authors.initials: CG
authors.lastname: Brilla
authors.forename: R L
authors.initials: RL
authors.lastname: Murphy
authors.forename: J F
authors.initials: JF
authors.lastname: Smits
authors.forename: H A
authors.initials: HA
authors.lastname: Struijker Boudier
authors.forename: L B
authors.initials: LB
authors.lastname: Tan
mesh_terms: D002318:Cardiovascular Diseases / Q000209:etiology; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000453:epidemiology / Q000473:pathology* / Q000503:physiopathology*; D012307:Risk Factors; D014481:United States / Q000453:epidemiology